Calquence 100 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FBANF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,188
Award facts
- Contract value 100% obligated
- $11,187.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $11,187.54. This firm fixed-price delivery order, with an ultimate completion date of November 20, 2025, represents a non-competitive set-aside award and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as the primary pharmaceutical supply vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contracting history demonstrates its capability to fulfill diverse pharmaceutical procurement needs through competitive awards. Calquence (acalabrutinib) is a targeted cancer therapy typically used in hematologic malignancies, reflecting the specialized nature of medications within the company's federal medical supply portfolio across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FBANF?
SPE2DB26FBANF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FBANF worth?
The government has obligated $11,188 on SPE2DB26FBANF.
Is contract SPE2DB26FBANF an order under another contract?
Yes. SPE2DB26FBANF is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB26FBANF competed?
The extent of competition for SPE2DB26FBANF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award